21 May 2013
Keywords: zeneca, accolate, linked, potentially, lethal, syndrome, issued
Article | 24 July 1997
Zeneca has issued a health advisory to physicians noting that its asthmadrug Accolate (zafirlukast) has been linked to a rare ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 July 1997
17 July 1997
© 2013 thepharmaletter.com